Objective The mainstay of treatment for most vulvar malignancies is surgery to the vulva with
lymphadenectomy to the inguino-femoral areas, plus radiotherapy or/and chemotherapy for …

OBJECTIVES: To investigate the efficacy of progestin treatment to achieve pathological
complete response (pCR) in patients with complex atypical endometrial hyperplasia (CAH) …

Background There are limited data from retrospective studies regarding whether survival
outcomes after laparoscopic or robot-assisted radical hysterectomy (minimally invasive …

Secondary lower-limb lymphedema can develop following treatment for gynecological
cancers, and has debilitating effects on quality of life (QoL). Lymphedema can limit mobility …

Hypoxia-inducible factor 1α (HIF-1α) is a transcriptional factor that regulates genes involved
in response to hypoxia and promotes neoangiogenesis, which are considered essential for …

Importance Standard treatment for endometrial cancer involves removal of the uterus, tubes,
ovaries, and lymph nodes. Few randomized trials have compared disease-free survival …

Background This two-stage randomised controlled trial, comparing total laparoscopic
hysterectomy (TLH) with total abdominal hysterectomy (TAH) for stage I endometrial cancer …

Purpose: The DESKTOP I trial proposed a score for the prediction of complete cytoreduction
in recurrent ovarian cancer. Resectability was assumed if 3 factors were present:(1) …

Purpose: To investigate the impact of expression of hypoxia-inducible factor (HIF)-1α on
prognosis and on response to chemotherapy in epithelial ovarian tumors. Experimental …

BACKGROUND. Few studies have evaluated lymphedema after gynecological cancer
treatment. The aim of this research was to establish prevalence, correlates, and supportive …